Thema: US17322U3068
CTXR, US17322U3068
stock-6687228_1920.jpg - Foto: THN
Citius Pharmaceuticals stock heads into Jefferies London conference
Citius Pharmaceuticals stock faces a scheduled investor conference in London from November 16 to 19. CEO Leonard Mazur will lead meetings.
ad-hoc-news.de, heute 01:51 Uhr
CTXR, US17322U3068
Citius Oncology reports 120% shipment growth for Citius ...
LYMPHIR shipments reached 792 units in fiscal Q4 2026, up from 360. Citius Pharmaceuticals stock awaits full results due in December 2026.
ad-hoc-news.de, 28.10.26 05:54 Uhr
